The Sutter Neuroscience Institute launches trial of cord blood stem cells in autistic kids

By Admin
The Sutter Neuroscience Institute in Sacramento has launched the innovative research to discover whether infusing umbilical cord stem cells into the bl...

The Sutter Neuroscience Institute in Sacramento has launched the innovative research to discover whether infusing umbilical cord stem cells into the blood streams of autistic children will help them overcome the debilitating characteristics of the condition.

Dr Michael Chez, the principal investigator and Sutter’s director of pediatric neurology said, “The clinical trial is the first of its kind to be approved by the U.S. Food and Drug Administration.”  

The research will also help in identifying a valuable new tool in the struggle against autism spectrum disorders which affects about 1 in 88 children nationwide and 1 in 54 boys.  

Chez said, “This is an exciting trial, because it is exposing us to the new frontier of stem cells and whether they may have some positive effect on this disease,” Mr. Chez said.  He also said, “This is the start of a new age of research in stem cell therapies for chronic diseases such as autism.” 

The present research has also revealed robust new uses for the stem cells.  According to a report by the Centre for Disease Control and Prevention, the likelihood of a child being given a diagnosis of an autism spectrum disorder increased more than 20% from 2006 to 2008.

The Sutter clinical trial follows promising research in using the cord blood stem cells to help the children with cerebral palsy to improve motor function.

Sutter Neuroscience Institute offers compassionate care, skilled diagnosis and advanced treatment for complex conditions of brain, spine and central nervous system for children and adults.

Share
Share

Featured Articles

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

This week in Healthcare Digital, we heard from experts in the sector: Trevor Dearing from Illumio, Avenda Health’s Brit Berry-Pusey & Vish Charan of Abbott

Lexica shares post-COVID-19 digital healthcare trends

Joanna Smith, Digital Advisory Lead at consulting company Lexica, explores the impact of COVID-19 on digital healthcare & what role health data can play

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma

Abbott’s CRM medical devices can help cardiac arrhythmia

Medical Devices & Pharma

AutoRABIT CEO Meredith Bell on DevOps strategy in healthcare

Hospitals